Loading…

Spanish version of the Mattis Dementia Rating Scale‐2 for early detection of Alzheimer's disease and mild cognitive impairment

Objective We aimed to analyse the clinical utility of the Mattis Dementia Rating Scale (MDRS‐2) for early detection of Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) in a sample of Spanish older adults. Methods A total of 125 participants (age = 75.12 ± 6.83, years of edu...

Full description

Saved in:
Bibliographic Details
Published in:International journal of geriatric psychiatry 2018-06, Vol.33 (6), p.832-840
Main Authors: Boycheva, Elina, Contador, Israel, Fernández‐Calvo, Bernardino, Ramos‐Campos, Francisco, Puertas‐Martín, Verónica, Villarejo‐Galende, Alberto, Bermejo‐Pareja, Félix
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3497-6ca3c0bc8c5dcd822708c1cdea8bae8f000f754760c12d5b69c1a6285e5733c13
cites cdi_FETCH-LOGICAL-c3497-6ca3c0bc8c5dcd822708c1cdea8bae8f000f754760c12d5b69c1a6285e5733c13
container_end_page 840
container_issue 6
container_start_page 832
container_title International journal of geriatric psychiatry
container_volume 33
creator Boycheva, Elina
Contador, Israel
Fernández‐Calvo, Bernardino
Ramos‐Campos, Francisco
Puertas‐Martín, Verónica
Villarejo‐Galende, Alberto
Bermejo‐Pareja, Félix
description Objective We aimed to analyse the clinical utility of the Mattis Dementia Rating Scale (MDRS‐2) for early detection of Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) in a sample of Spanish older adults. Methods A total of 125 participants (age = 75.12 ± 6.83, years of education =7.08 ± 3.57) were classified in three diagnostic groups: 45 patients with mild AD, 37 with amnestic MCI—single and multiple domain and 43 cognitively healthy controls (HCs). Reliability, criterion validity and diagnostic accuracy of the MDRS‐2 (total and subscales) were analysed. The MDRS‐2 scores, adjusted by socio‐demographic characteristics, were calculated through hierarchical multiple regression analysis. Results The global scale had adequate reliability (α = 0.736) and good criterion validity (r = 0.760, p 
doi_str_mv 10.1002/gps.4707
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1880470197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2033676224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3497-6ca3c0bc8c5dcd822708c1cdea8bae8f000f754760c12d5b69c1a6285e5733c13</originalsourceid><addsrcrecordid>eNp1kc1OGzEQx60KVFJaqU-ALHFoLwv-yNreY0T5qAQCkfZsee3ZxNF-YTugcOIReEaehE1JQULiNIf5zU8z80foOyUHlBB2OOvjwVgS-QmNKCmKjFIhttCIKJVngnGyg77EuCBk6FH1Ge0wxTmTnI3Qw7Q3rY9zfAsh-q7FXYXTHPCFSclH_AsaaJM3-Nok387w1Joanh4eGa66gMGEeoUdJLBpMzup7-fgGwg_InY-gomATetw42uHbTdrffK3gH3TGx_W7q9ouzJ1hG-buov-nhz_OTrLzi9Pfx9NzjPLx4XMhDXcktIqmzvrFGOSKEutA6NKA6oabqtkPpaCWMpcXorCUiOYyiGXnFvKd9HPF28fupslxKQbHy3UtWmhW0ZNlSLDC2khB3T_HbrolqEdttOMcC6kYGz8JrShizFApfvgGxNWmhK9TkUPqeh1KgO6txEuywbcK_g_hgHIXoA7X8PqQ5E-vZr-Ez4D1teXfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2033676224</pqid></control><display><type>article</type><title>Spanish version of the Mattis Dementia Rating Scale‐2 for early detection of Alzheimer's disease and mild cognitive impairment</title><source>Wiley</source><creator>Boycheva, Elina ; Contador, Israel ; Fernández‐Calvo, Bernardino ; Ramos‐Campos, Francisco ; Puertas‐Martín, Verónica ; Villarejo‐Galende, Alberto ; Bermejo‐Pareja, Félix</creator><creatorcontrib>Boycheva, Elina ; Contador, Israel ; Fernández‐Calvo, Bernardino ; Ramos‐Campos, Francisco ; Puertas‐Martín, Verónica ; Villarejo‐Galende, Alberto ; Bermejo‐Pareja, Félix</creatorcontrib><description>Objective We aimed to analyse the clinical utility of the Mattis Dementia Rating Scale (MDRS‐2) for early detection of Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) in a sample of Spanish older adults. Methods A total of 125 participants (age = 75.12 ± 6.83, years of education =7.08 ± 3.57) were classified in three diagnostic groups: 45 patients with mild AD, 37 with amnestic MCI—single and multiple domain and 43 cognitively healthy controls (HCs). Reliability, criterion validity and diagnostic accuracy of the MDRS‐2 (total and subscales) were analysed. The MDRS‐2 scores, adjusted by socio‐demographic characteristics, were calculated through hierarchical multiple regression analysis. Results The global scale had adequate reliability (α = 0.736) and good criterion validity (r = 0.760, p &lt; .001) with the Mini‐Mental State Examination. The optimal cut‐off point between AD patients and HCs was 124 (sensitivity [Se] = 97% and specificity [Sp] = 95%), whereas 131 (Se = 89%, Sp = 81%) was the optimal cut‐off point between MCI and HCs. An optimal cut‐off point of 123 had good Se (0.97), but poor Sp (0.56) to differentiate AD and MCI groups. The Memory and Initiation/Perseveration subscales had the highest discriminative capacity between the groups. Conclusions The MDRS‐2 is a reliable and valid instrument for the assessment of cognitive impairment in Spanish older adults. In particular, optimal capacity emerged for the detection of early AD and MCI. Copyright © 2017 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0885-6230</identifier><identifier>EISSN: 1099-1166</identifier><identifier>DOI: 10.1002/gps.4707</identifier><identifier>PMID: 28332732</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Aged ; Aged, 80 and over ; Alzheimer Disease - diagnosis ; Alzheimer Disease - psychology ; Alzheimer's disease ; clinical validity ; Cognitive ability ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - psychology ; Dementia ; Dementia disorders ; early detection ; Early Diagnosis ; Female ; Geriatric psychiatry ; Hispanic Americans ; Humans ; Male ; Memory ; Mental Status and Dementia Tests ; Middle Aged ; mild cognitive impairment ; Multiple regression analysis ; Neurodegenerative diseases ; neuropsychological assessment ; older adults ; Older people ; Psychometrics - standards ; Regression Analysis ; Reproducibility of Results ; Sensitivity and Specificity</subject><ispartof>International journal of geriatric psychiatry, 2018-06, Vol.33 (6), p.832-840</ispartof><rights>Copyright © 2017 John Wiley &amp; Sons, Ltd.</rights><rights>Copyright © 2018 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3497-6ca3c0bc8c5dcd822708c1cdea8bae8f000f754760c12d5b69c1a6285e5733c13</citedby><cites>FETCH-LOGICAL-c3497-6ca3c0bc8c5dcd822708c1cdea8bae8f000f754760c12d5b69c1a6285e5733c13</cites><orcidid>0000-0002-9506-8491 ; 0000-0001-8080-5578</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28332732$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boycheva, Elina</creatorcontrib><creatorcontrib>Contador, Israel</creatorcontrib><creatorcontrib>Fernández‐Calvo, Bernardino</creatorcontrib><creatorcontrib>Ramos‐Campos, Francisco</creatorcontrib><creatorcontrib>Puertas‐Martín, Verónica</creatorcontrib><creatorcontrib>Villarejo‐Galende, Alberto</creatorcontrib><creatorcontrib>Bermejo‐Pareja, Félix</creatorcontrib><title>Spanish version of the Mattis Dementia Rating Scale‐2 for early detection of Alzheimer's disease and mild cognitive impairment</title><title>International journal of geriatric psychiatry</title><addtitle>Int J Geriatr Psychiatry</addtitle><description>Objective We aimed to analyse the clinical utility of the Mattis Dementia Rating Scale (MDRS‐2) for early detection of Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) in a sample of Spanish older adults. Methods A total of 125 participants (age = 75.12 ± 6.83, years of education =7.08 ± 3.57) were classified in three diagnostic groups: 45 patients with mild AD, 37 with amnestic MCI—single and multiple domain and 43 cognitively healthy controls (HCs). Reliability, criterion validity and diagnostic accuracy of the MDRS‐2 (total and subscales) were analysed. The MDRS‐2 scores, adjusted by socio‐demographic characteristics, were calculated through hierarchical multiple regression analysis. Results The global scale had adequate reliability (α = 0.736) and good criterion validity (r = 0.760, p &lt; .001) with the Mini‐Mental State Examination. The optimal cut‐off point between AD patients and HCs was 124 (sensitivity [Se] = 97% and specificity [Sp] = 95%), whereas 131 (Se = 89%, Sp = 81%) was the optimal cut‐off point between MCI and HCs. An optimal cut‐off point of 123 had good Se (0.97), but poor Sp (0.56) to differentiate AD and MCI groups. The Memory and Initiation/Perseveration subscales had the highest discriminative capacity between the groups. Conclusions The MDRS‐2 is a reliable and valid instrument for the assessment of cognitive impairment in Spanish older adults. In particular, optimal capacity emerged for the detection of early AD and MCI. Copyright © 2017 John Wiley &amp; Sons, Ltd.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer Disease - psychology</subject><subject>Alzheimer's disease</subject><subject>clinical validity</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - psychology</subject><subject>Dementia</subject><subject>Dementia disorders</subject><subject>early detection</subject><subject>Early Diagnosis</subject><subject>Female</subject><subject>Geriatric psychiatry</subject><subject>Hispanic Americans</subject><subject>Humans</subject><subject>Male</subject><subject>Memory</subject><subject>Mental Status and Dementia Tests</subject><subject>Middle Aged</subject><subject>mild cognitive impairment</subject><subject>Multiple regression analysis</subject><subject>Neurodegenerative diseases</subject><subject>neuropsychological assessment</subject><subject>older adults</subject><subject>Older people</subject><subject>Psychometrics - standards</subject><subject>Regression Analysis</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><issn>0885-6230</issn><issn>1099-1166</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kc1OGzEQx60KVFJaqU-ALHFoLwv-yNreY0T5qAQCkfZsee3ZxNF-YTugcOIReEaehE1JQULiNIf5zU8z80foOyUHlBB2OOvjwVgS-QmNKCmKjFIhttCIKJVngnGyg77EuCBk6FH1Ge0wxTmTnI3Qw7Q3rY9zfAsh-q7FXYXTHPCFSclH_AsaaJM3-Nok387w1Joanh4eGa66gMGEeoUdJLBpMzup7-fgGwg_InY-gomATetw42uHbTdrffK3gH3TGx_W7q9ouzJ1hG-buov-nhz_OTrLzi9Pfx9NzjPLx4XMhDXcktIqmzvrFGOSKEutA6NKA6oabqtkPpaCWMpcXorCUiOYyiGXnFvKd9HPF28fupslxKQbHy3UtWmhW0ZNlSLDC2khB3T_HbrolqEdttOMcC6kYGz8JrShizFApfvgGxNWmhK9TkUPqeh1KgO6txEuywbcK_g_hgHIXoA7X8PqQ5E-vZr-Ez4D1teXfA</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Boycheva, Elina</creator><creator>Contador, Israel</creator><creator>Fernández‐Calvo, Bernardino</creator><creator>Ramos‐Campos, Francisco</creator><creator>Puertas‐Martín, Verónica</creator><creator>Villarejo‐Galende, Alberto</creator><creator>Bermejo‐Pareja, Félix</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9506-8491</orcidid><orcidid>https://orcid.org/0000-0001-8080-5578</orcidid></search><sort><creationdate>201806</creationdate><title>Spanish version of the Mattis Dementia Rating Scale‐2 for early detection of Alzheimer's disease and mild cognitive impairment</title><author>Boycheva, Elina ; Contador, Israel ; Fernández‐Calvo, Bernardino ; Ramos‐Campos, Francisco ; Puertas‐Martín, Verónica ; Villarejo‐Galende, Alberto ; Bermejo‐Pareja, Félix</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3497-6ca3c0bc8c5dcd822708c1cdea8bae8f000f754760c12d5b69c1a6285e5733c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer Disease - psychology</topic><topic>Alzheimer's disease</topic><topic>clinical validity</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - psychology</topic><topic>Dementia</topic><topic>Dementia disorders</topic><topic>early detection</topic><topic>Early Diagnosis</topic><topic>Female</topic><topic>Geriatric psychiatry</topic><topic>Hispanic Americans</topic><topic>Humans</topic><topic>Male</topic><topic>Memory</topic><topic>Mental Status and Dementia Tests</topic><topic>Middle Aged</topic><topic>mild cognitive impairment</topic><topic>Multiple regression analysis</topic><topic>Neurodegenerative diseases</topic><topic>neuropsychological assessment</topic><topic>older adults</topic><topic>Older people</topic><topic>Psychometrics - standards</topic><topic>Regression Analysis</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boycheva, Elina</creatorcontrib><creatorcontrib>Contador, Israel</creatorcontrib><creatorcontrib>Fernández‐Calvo, Bernardino</creatorcontrib><creatorcontrib>Ramos‐Campos, Francisco</creatorcontrib><creatorcontrib>Puertas‐Martín, Verónica</creatorcontrib><creatorcontrib>Villarejo‐Galende, Alberto</creatorcontrib><creatorcontrib>Bermejo‐Pareja, Félix</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boycheva, Elina</au><au>Contador, Israel</au><au>Fernández‐Calvo, Bernardino</au><au>Ramos‐Campos, Francisco</au><au>Puertas‐Martín, Verónica</au><au>Villarejo‐Galende, Alberto</au><au>Bermejo‐Pareja, Félix</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spanish version of the Mattis Dementia Rating Scale‐2 for early detection of Alzheimer's disease and mild cognitive impairment</atitle><jtitle>International journal of geriatric psychiatry</jtitle><addtitle>Int J Geriatr Psychiatry</addtitle><date>2018-06</date><risdate>2018</risdate><volume>33</volume><issue>6</issue><spage>832</spage><epage>840</epage><pages>832-840</pages><issn>0885-6230</issn><eissn>1099-1166</eissn><abstract>Objective We aimed to analyse the clinical utility of the Mattis Dementia Rating Scale (MDRS‐2) for early detection of Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) in a sample of Spanish older adults. Methods A total of 125 participants (age = 75.12 ± 6.83, years of education =7.08 ± 3.57) were classified in three diagnostic groups: 45 patients with mild AD, 37 with amnestic MCI—single and multiple domain and 43 cognitively healthy controls (HCs). Reliability, criterion validity and diagnostic accuracy of the MDRS‐2 (total and subscales) were analysed. The MDRS‐2 scores, adjusted by socio‐demographic characteristics, were calculated through hierarchical multiple regression analysis. Results The global scale had adequate reliability (α = 0.736) and good criterion validity (r = 0.760, p &lt; .001) with the Mini‐Mental State Examination. The optimal cut‐off point between AD patients and HCs was 124 (sensitivity [Se] = 97% and specificity [Sp] = 95%), whereas 131 (Se = 89%, Sp = 81%) was the optimal cut‐off point between MCI and HCs. An optimal cut‐off point of 123 had good Se (0.97), but poor Sp (0.56) to differentiate AD and MCI groups. The Memory and Initiation/Perseveration subscales had the highest discriminative capacity between the groups. Conclusions The MDRS‐2 is a reliable and valid instrument for the assessment of cognitive impairment in Spanish older adults. In particular, optimal capacity emerged for the detection of early AD and MCI. Copyright © 2017 John Wiley &amp; Sons, Ltd.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28332732</pmid><doi>10.1002/gps.4707</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-9506-8491</orcidid><orcidid>https://orcid.org/0000-0001-8080-5578</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0885-6230
ispartof International journal of geriatric psychiatry, 2018-06, Vol.33 (6), p.832-840
issn 0885-6230
1099-1166
language eng
recordid cdi_proquest_miscellaneous_1880470197
source Wiley
subjects Aged
Aged, 80 and over
Alzheimer Disease - diagnosis
Alzheimer Disease - psychology
Alzheimer's disease
clinical validity
Cognitive ability
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - psychology
Dementia
Dementia disorders
early detection
Early Diagnosis
Female
Geriatric psychiatry
Hispanic Americans
Humans
Male
Memory
Mental Status and Dementia Tests
Middle Aged
mild cognitive impairment
Multiple regression analysis
Neurodegenerative diseases
neuropsychological assessment
older adults
Older people
Psychometrics - standards
Regression Analysis
Reproducibility of Results
Sensitivity and Specificity
title Spanish version of the Mattis Dementia Rating Scale‐2 for early detection of Alzheimer's disease and mild cognitive impairment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A31%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spanish%20version%20of%20the%20Mattis%20Dementia%20Rating%20Scale%E2%80%902%20for%20early%20detection%20of%20Alzheimer's%20disease%20and%20mild%20cognitive%20impairment&rft.jtitle=International%20journal%20of%20geriatric%20psychiatry&rft.au=Boycheva,%20Elina&rft.date=2018-06&rft.volume=33&rft.issue=6&rft.spage=832&rft.epage=840&rft.pages=832-840&rft.issn=0885-6230&rft.eissn=1099-1166&rft_id=info:doi/10.1002/gps.4707&rft_dat=%3Cproquest_cross%3E2033676224%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3497-6ca3c0bc8c5dcd822708c1cdea8bae8f000f754760c12d5b69c1a6285e5733c13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2033676224&rft_id=info:pmid/28332732&rfr_iscdi=true